Treatment of the Biceps With Concomitant Supraspinatus Tears

NCT ID: NCT05660031

Last Updated: 2025-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-01

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology.Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact. The primary goal of this prospective multicenter randomized study is to evaluate whether LHB tenodesis grants superior post-operative functional outcomes compared to LHB tenotomy or leaving the LHB intact in patients undergoing rotator cuff repair (RCR) for an isolated full-thickness lesion of the supraspinatus. The primary goal of this prospective multicenter randomized study is to evaluate whether LHB tenodesis grants superior post-operative functional outcomes compared to LHB tenotomy or leaving the LHB intact in patients undergoing rotator cuff repair (RCR) for an isolated full-thickness lesion of the supraspinatus. The secondary goals are to determine whether there is a difference in post-operative functional outcomes between the LHB tenotomy group and the Intact LHB group, and if there is a difference in complication rates or patient satisfaction between the three groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Supraspinatus Tear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Leaving LHB Intact

The long head of the biceps (LHB) will be left intact.

Group Type NO_INTERVENTION

No interventions assigned to this group

LHB tenotomy

The long head of the biceps (LHB) will be cut at its origin.

Group Type EXPERIMENTAL

LHB Tenotomy

Intervention Type PROCEDURE

Will be performed arthroscopically by cutting the LHB at its origin with arthroscopic scissors

LHB Tenodesis

The long head of the biceps (LHB) will be cut at its origin and reattached.

Group Type EXPERIMENTAL

LHB Tenodesis

Intervention Type PROCEDURE

"ill be performed arthroscopically with a tenodesis at the top of the articular margin using an onlay technique.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LHB Tenotomy

Will be performed arthroscopically by cutting the LHB at its origin with arthroscopic scissors

Intervention Type PROCEDURE

LHB Tenodesis

"ill be performed arthroscopically with a tenodesis at the top of the articular margin using an onlay technique.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy.
* Full thickness tear of the supraspinatus tendon
* Intact subscapularis tendon
* Primary rotator cuff repair
* Age 50-80

Exclusion Criteria

* Previous full thickness biceps tear
* Infection and neuropathic joints
* Known or suspected non-compliance, drug or alcohol abuse
* Patients incapable of judgement or under tutelage
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, contraindication for MRI scan etc.
* Enrolment of the investigator, his/her family members, employees and other dependent persons
* Patient declines to participate in study
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

La Tour Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Alexandre Lädermann

Orthopaedic Surgeon FMH, Shoulder and Elbow Surgery Traumatology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexandre Lädermann, MD

Role: PRINCIPAL_INVESTIGATOR

La Tour Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sports Medicine and Shoulder Surgery, University of Michigan

Ann Arbor, Michigan, United States

Site Status RECRUITING

Oregon Health & Science University

Portland, Oregon, United States

Site Status RECRUITING

Group 23 Sports Medicine

Calgary, Alberta, Canada

Site Status RECRUITING

la Tour hospital

Meyrin, Canton of Geneva, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Canada Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexandre Lädermann, MD

Role: CONTACT

+41 22 71 975 55

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Asheesh Bedi, MD

Role: primary

Patrick Denard, MD

Role: primary

Ian K Lo, MD

Role: primary

Alexandre Lädermann, MD

Role: primary

+41 22 719 75 55

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-00066

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tuberoplasty Versus Balloon Spacer
NCT06735170 RECRUITING PHASE1/PHASE2
Biceps Tenodesis Versus Tenotomy
NCT01747902 COMPLETED NA
Tendon Transfer Rotator Cuff Tear
NCT04588506 TERMINATED NA
Superior Capsule vs Bridging Study
NCT04965103 COMPLETED NA